share_log

Investors in Quaker Chemical (NYSE:KWR) Have Unfortunately Lost 29% Over the Last Three Years

Investors in Quaker Chemical (NYSE:KWR) Have Unfortunately Lost 29% Over the Last Three Years

不幸的是,贵格化学(纽约证券交易所代码:KWR)的投资者在过去三年中损失了29%
Simply Wall St ·  02/15 05:08

Quaker Chemical Corporation (NYSE:KWR) shareholders should be happy to see the share price up 13% in the last quarter. But that doesn't help the fact that the three year return is less impressive. Truth be told the share price declined 31% in three years and that return, Dear Reader, falls short of what you could have got from passive investing with an index fund.

贵格化学公司(纽约证券交易所代码:KWR)的股东应该对上个季度股价上涨13%感到高兴。但这无助于三年回报率不那么令人印象深刻的事实。说实话,股价在三年内下跌了31%,亲爱的读者,这一回报没有达到指数基金被动投资所能获得的回报。

With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.

考虑到这一点,值得一看公司的基本面是否是长期业绩的驱动力,或者是否存在一些差异。

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

不可否认,市场有时是有效的,但价格并不总是能反映潜在的业务表现。通过比较每股收益(EPS)和一段时间内的股价变化,我们可以了解投资者对公司的态度是如何随着时间的推移而变化的。

During the unfortunate three years of share price decline, Quaker Chemical actually saw its earnings per share (EPS) improve by 36% per year. Given the share price reaction, one might suspect that EPS is not a good guide to the business performance during the period (perhaps due to a one-off loss or gain). Or else the company was over-hyped in the past, and so its growth has disappointed.

在不幸的三年股价下跌中,贵格化学的每股收益(EPS)实际上每年增长36%。鉴于股价的反应,人们可能会怀疑每股收益并不能很好地指导该期间的业务表现(可能是由于一次性的亏损或收益)。否则,该公司过去曾被过度炒作,因此其增长令人失望。

It's worth taking a look at other metrics, because the EPS growth doesn't seem to match with the falling share price.

值得一看其他指标,因为每股收益的增长似乎与股价的下跌不符。

With a rather small yield of just 0.9% we doubt that the stock's share price is based on its dividend. Revenue is actually up 12% over the three years, so the share price drop doesn't seem to hinge on revenue, either. This analysis is just perfunctory, but it might be worth researching Quaker Chemical more closely, as sometimes stocks fall unfairly. This could present an opportunity.

由于收益率相当低,仅为0.9%,我们怀疑该股的股价是否基于其股息。在过去的三年中,收入实际上增长了12%,因此股价下跌似乎也不取决于收入。这种分析只是敷衍了事,但可能值得对贵格化学进行更仔细的研究,因为有时股票会不公平地下跌。这可能带来机会。

The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).

公司的收入和收益(随着时间的推移)如下图所示(点击查看确切数字)。

earnings-and-revenue-growth
NYSE:KWR Earnings and Revenue Growth February 15th 2024
纽约证券交易所:KWR 收益和收入增长 2024 年 2 月 15 日

We're pleased to report that the CEO is remunerated more modestly than most CEOs at similarly capitalized companies. But while CEO remuneration is always worth checking, the really important question is whether the company can grow earnings going forward. So we recommend checking out this free report showing consensus forecasts

我们很高兴地向大家报告,首席执行官的薪酬比资本状况相似的公司的大多数首席执行官更适中。但是,尽管首席执行官的薪酬总是值得检查的,但真正重要的问题是公司未来能否增加收益。因此,我们建议您查看这份显示共识预测的免费报告

A Different Perspective

不同的视角

Investors in Quaker Chemical had a tough year, with a total loss of 4.9% (including dividends), against a market gain of about 20%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 0.8% over the last half decade. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. To that end, you should be aware of the 3 warning signs we've spotted with Quaker Chemical .

贵格化学的投资者经历了艰难的一年,总亏损为4.9%(包括股息),而市场涨幅约为20%。但是,请记住,即使是最好的股票有时也会在十二个月内表现不如市场。不幸的是,去年的表现可能预示着尚未解决的挑战,因为它比过去五年0.8%的年化亏损还要糟糕。总的来说,长期股价疲软可能是一个坏兆头,尽管逆势投资者可能希望研究该股以期出现转机。我发现将长期股价视为业务绩效的代表非常有趣。但是,要真正获得见解,我们还需要考虑其他信息。为此,你应该注意我们在贵格化学发现的3个警告信号。

But note: Quaker Chemical may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

但请注意:贵格化学可能不是最好的买入股票。因此,来看看这份过去盈利增长(以及进一步增长预测)的有趣公司的免费清单。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

请注意,本文引用的市场回报反映了目前在美国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发